Delivery Order SPE2DB22D2007-SPE2DB24FJ3ZC
Award Date
7/8/24
Potential Completion Date
7/9/24
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,775.46 firm fixed-price delivery order is for the supply of 100 mg MICAFUNGIN vials. The contract has an ultimate completion date of June 6, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which...
This federal contract award is for the delivery of MICAFUNGIN 50 MG VIALS to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $4,087.19, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of June 9, 2025. There is no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,997.18 firm-fixed-price delivery order is for the supply of MICAFUNGIN 50 MG VIALS, a pharmaceutical product. The contract has a period of performance extending until June 10, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $1,110.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 50 mg vials of the antifungal medication micafungin. This contract is a Delivery Order placed under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a range...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order worth $8,459.74 from the Defense Logistics Agency (DLA) Troop Support Medical for the provision of pharmaceutical products and medical supplies. The award is under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $1,135.40, is for the delivery of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide a comprehensive range of medications, devices, and critical...
This federal contract award, valued at $13,866.38, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and...
This federal contract award, valued at $1,082.10, was issued to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which has a potential value of up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies to...
This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, worth $1,529.39, is a delivery order for the provision of pharmaceutical and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 through December 31, 2025. This...
This federal contract award, valued at $1,702.71, was issued to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies to support the Department of...